Clinical trials: GastroIntestinal Bleeding, open to volunteers

Cirrhosis, Liver

Utility of ROTEM® for Risk Stratification of Post-Invasive Procedure Hemorrhage in Patients With Cirrhosis (CIR-ROTEM)

• Recruiting
• Age: 18 to 65 years
• Observational study
• Medical device

The assessment of post-procedural bleeding risk in cirrhosis remains a clinical challenge due to the lack of precise predictive tools and its high associated mortality.

Trial name

CIR-ROTEM (NCT06908785)

Testing

Rotational thromboelastometry

Where

11 sites in Spain

Volunteers

330 people

Sponsor

Instituto de Investigación Marqués de Valdecilla